業績

  • 2011年

    ｜　Ａ．原著・症例報告　

    Ａ．原著・症例報告

    • Kuwahara Y, Oikawa T, Ochiai Y, Roudkenar MH, Fukumoto M, Shimura T, OhtakeY, Ohkubo Y, Mori S, Uchiyama Y, Fukumoto M.. Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy. Cell Death Dis.2011 Jun 30;2:e177.
    • Shiozaki M, Hayakawa N, Shibata M, Koike M, Uchiyama Y, Gotow T. Closer association of mitochondria with lipid droplets in hepatocytes and activation of Kupffer cells in resveratrol-treated senescence-accelerated mice. Histochem Cell Biol.2011 Oct;136(4):475-89.
    • Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, Kobayashi Y, Fujiyoshi K, Koike M, Uchiyama Y, Ikeda E, Toyama Y, Yamanaka S, Nakamura M, Okano H. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA. 2011 Oct 4;108(40):16825-30.
    • Uchida Y, Hasegawa J, Chinnapen D, Inoue T, Okazaki S, Kato R, Wakatsuki S, Misaki R, Koike M, Uchiyama Y, Iemura S, Natsume T, Kuwahara R, Nakagawa T, Nishikawa K, Mukai K, Miyoshi E, Taniguchi N, Sheff D, Lencer WI, Taguchi T, Arai H. Intracellular phosphatidylserine is essential for retrograde membrane traffic through endosomes. Proc Natl Acad Sci USA.2011 Sep 20;108(38):15846-51.
    • Koyanagi M, Asahara A, Matsuda T, Hashimoto N, Shigeyama Y, Shibutani Y, Hosooka T, Inoue H, Matsumoto H, Koike M, Uchiyama Y, NodaT, Seino S, Kasuga M, Kido Y. Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1. ProS One.2011;6(8) :e23238.
    • Oguro M, Koike M, Ueno T, Asaoka D, Mori H, Nagahara A, Uchiyama Y, Watanabe S. Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease.J Gastroenterol.2011 May;46(5):629-38.
    • Hattori N, Eguchi H, Imaizumi M, Saiki S, Sato S, Nagamatsu S. [The pathomechanisms of young-onset Parkinson’s disease (PD), approach to the causes of PD form the mechanisms of insulin secretion system]. Rinsho Shinkeigaku. 2011 Nov;51(11):986-7. Japanese.
    • Miyamoto N, Tanaka Y, Ueno Y, Kawamura M, Shimada Y, Tanaka R, Hattori N, Urabe T. Demographic, Clinical, and Radiologic Predictors of Neurologic Deterioration in Patients with Acute Ischemic Stroke. J Stroke Cerebrovasc Dis.2011 Sep 7. [Epub ahead of print]
    • Yamashiro K, Furuya T, Noda K, Urabe T, Hattori N, Okuma Y. Convulsive movements in bilateral paramedian thalamic and midbrain infarction. Case Rep Neurol. 2011 Sep;3(3):289-93.
    • Kawanabe T, Tanaka R, Sakaguchi Y, Akiyama O, Shimura H, Yasumoto Y, Ito M, Hattori N, Tanaka S. Posterior reversible encephalopathy syndrome complicating intracranial hemorrhage after phenylpropanolamine exposure. Neurol Med Chir (Tokyo). 2011;51(8):582-5.
    • Sato S, Hattori N. Genetic mutations and mitochondrial toxins shed new light on the pathogenesis of Parkinson’s disease. Parkinsons Dis. 2011;2011:979231. Epub 2011 Aug 1.
    • Kawajiri S, Saiki S, Sato S, Hattori N. Genetic mutations and functions of PINK1. Trends Pharmacol Sci. 2011 Oct;32(10):573-80.
    • Usami Y, Hatano T, Imai S, Kubo S, Sato S, Saiki S, Fujioka Y, Ohba Y, Sato F, Funayama M, Eguchi H, Shiba K, Ariga H, Shen J, Hattori N. DJ-1 associates with synaptic membranes. Neurobiol Dis. 2011 Sep;43(3):651-62.
    • Noda K, Fukae J, Fujishima K, Mori K, Urabe T, Hattori N, Okuma Y. Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage, reversible posterior leukoencephalopathy, and cerebral infarction. Intern Med. 2011;50(11):1227-33.
    • Kamagata K, Motoi Y, Hori M, Suzuki M, Nakanishi A, Shimoji K, Kyougoku S, Kuwatsuru R, Sasai K, Abe O, Mizuno Y, Aoki S, Hattori N. Posterior hypoperfusion in Parkinson’s disease with and without dementia measured with arterial spin labeling MRI. J Magn Reson Imaging. 2011 Apr;33(4):803-7.
    • Tomiyama H, Yoshino H, Ogaki K, Li L, Yamashita C, Li Y, Funayama M, Sasaki R, Kokubo Y, Kuzuhara S, Hattori N. PLA2G6 variant in Parkinson’s disease. J Hum Genet. 2011 May;56(5):401-3.
    • Kambe T, Motoi Y, Inoue R, Kojima N, Tada N, Kimura T, Sahara N, Yamashita S, Mizoroki T, Takashima A, Shimada K, Ishiguro K, Mizuma H, Onoe H, Mizuno Y, Hattori N. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice. Neurobiol Dis. 2011 Jun;42(3):404-14.
    • Yoritaka A, Shimo Y, Shimo Y, Inoue Y, Yoshino H, Hattori N. Nonmotor Symptoms in Patients with PARK2 Mutations. Parkinsons Dis. 2011 Jan 13;2011:4736-40.
    • Oyama G, Shimo Y, Natori S, Nakajima M, Ishii H, Arai H, Hattori N. Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson’s disease. Parkinsonism Relat Disord. 2011 Mar;17(3):189-93.
    • Hatano T, Shimada Y, Kono A, Kubo S, Yokoyama K, Yoritaka A, Nakahara T, Takahashi Y, Hattori N. Atypical Miller Fisher syndrome associated with glutamate receptor antibodies. BMJ Case Rep. 2011 Sep 8;2011. pii: bcr0820103228. doi: 10.1136/bcr.08.2010.3228.
    • Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I, Kobayashi H, Sato F, Sato S, Ishikawa K, Imoto M, Hattori N. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 2011 Feb;7(2):176-87.
    • Ning L, Ishijima M, Kaneko H, Kurihara H, Arikawa-Hirasawa E, Kubota
      M, Liu L, Xu Z, Futami I, Yusup A, Miyahara K, Xu S, Kaneko K, Kurosawa H,.Correlations between both the expression levels of inflammatory mediators and growth factor in medial perimeniscal synovial tissue and the severity of medial knee osteoarthritis. Int Orthop 2011 Jun;35(6):831-8.
    • Chyba M, Mercier F, Rader J, Douet V, Arikawa-Hirasawa E, Kwon YC,Kodama R. Dynamic mathematical modeling of cell-fractone interactions Journal of Math-for-Industry, Vol. 3 (2011A-8), pp. 79-88
    • Hayashi C, Funayama M, Li Y, Kawano A, Suzuki M, Hattori N, Ikeda K. Prevalence of GJB2 Causing Recessive Profound Non-Syndromic Deafness in Japanese Children. Int J Pediatr Otorhinolaryngol. 2011 Feb;75(2):211-4.
    • Tomiyama H, Yoshino H, Ogaki K, Li L, Yamashita C, Li Y, Funayama M, Sasaki R, Kokubo Y, Kuzuhara S, Hattori N. PLA2G6 variant in Parkinson’s disease. J Hum Genet. 2011 May;56(5):401-3.